Evidence map›Paper›PMID 37055522›Full record

ArticleBritish journal of cancer2023

Correction to: Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site.

Maud Kamal, Sonia Lameiras, Marc Deloger, Adeline Morel, Sophie Vacher, Charlotte Lecerf, Célia Dupain, Emmanuelle Jeannot, Elodie Girard, Sylvain Baulande and 14 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Maud KamalDepartment of Drug Development and Innovation, Institut Curie, PSL Research University, 75005 Paris & 92210, Saint-Cloud, France. maud.kamal@curie.fr.
Sonia LameirasInstitut Curie, Genomics of Excellence (ICGex) Platform, PSL Research University, 75005, Paris, France.
Marc DelogerBioinformatics and Computational Systems Biology of Cancer, PSL Research University, Mines Paris Tech, INSERM U900, 75005, Paris, France.
Adeline MorelDepartment of Genetics, Institut Curie, PSL Research University, 75005, Paris, France.
Sophie VacherDepartment of Genetics, Institut Curie, PSL Research University, 75005, Paris, France.
Charlotte LecerfDepartment of Drug Development and Innovation, Institut Curie, PSL Research University, 75005 Paris & 92210, Saint-Cloud, France.
Célia DupainDepartment of Drug Development and Innovation, Institut Curie, PSL Research University, 75005 Paris & 92210, Saint-Cloud, France.
Emmanuelle JeannotDepartment of Genetics, Institut Curie, PSL Research University, 75005, Paris, France.ORCID http://orcid.org/0000-0002-4851-7450
Elodie GirardBioinformatics and Computational Systems Biology of Cancer, PSL Research University, Mines Paris Tech, INSERM U900, 75005, Paris, France.
Sylvain BaulandeInstitut Curie, Genomics of Excellence (ICGex) Platform, PSL Research University, 75005, Paris, France.
Coraline DubotDepartment of Drug Development and Innovation, Institut Curie, PSL Research University, 75005 Paris & 92210, Saint-Cloud, France.
Gemma KenterCenter for Gynaecologic Oncology Amsterdam, Amsterdam UMC and The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Ekaterina S JordanovaCenter for Gynaecologic Oncology Amsterdam, Amsterdam UMC and The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-8121-1322
Els M J J BernsDepartment of Medical Oncology, Erasmus MC, 3000 CA, Rotterdam, The Netherlands.
Guillaume BataillonDepartment of Pathology, Institut Curie, PSL Research University, 75005, Paris, France.
Marina PopovicOncology Institute of Vojvodina, Put doktora Goldmana, 421204, Sremska Kamenica, Serbia.
Roman RouzierDepartment of Surgery, Institut Curie, PSL Research University, 92210, Saint-Cloud, France.
Wulfran CacheuxHopital Privé Pays de Savoie, Service d'oncologie médicale, 19 avenue Pierre Mendès France, 74100, Annemasse, France.
Christophe Le TourneauDepartment of Drug Development and Innovation, Institut Curie, PSL Research University, 75005 Paris & 92210, Saint-Cloud, France.ORCID http://orcid.org/0000-0001-9772-4686
Alain NicolasInstitut Curie, PSL Research University, CNRS UMR3244, 75248, Paris, France.
Nicolas ServantBioinformatics and Computational Systems Biology of Cancer, PSL Research University, Mines Paris Tech, INSERM U900, 75005, Paris, France.
Suzy M Scholl *Department of Drug Development and Innovation, Institut Curie, PSL Research University, 75005 Paris & 92210, Saint-Cloud, France.
Ivan Bièche *Department of Genetics, Institut Curie, PSL Research University, 75005, Paris, France.
RAIDs Consortium

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37055522
PMCPMC10133217

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.